MedTrace Logo

Dental Implants in Patients Under Oral Anticoagulant Therapy

NCT04846114 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2022-10-12

No results posted yet for this study

Summary

This study evaluated the outcomes in the post-operative recovery following dental implant surgery in patients who continued on oral anticoagulated therapy (OAT) with warfarin. The primary outcome of this study was to evaluate bleeding within the first 5 days post-surgery and presence of intraoral/extraoral hematomas in skin and mucosa oral.

Conditions

  • Oral Anticoagulant Therapy

Interventions

PROCEDURE

Dental implant surgery

Sponsors & Collaborators

  • Jorge Ernesto Aguilar

    lead OTHER

Principal Investigators

  • Jorge Aguilar, Chair Prof · Universidad del Salvador

  • Mariano Vassallo, Assoc Prof · Universidad del Salvador

  • Jose Zamberlin, Assoc Prof · Universidad del Salvador

  • Marina Diaz Roig, Assist Prof · Universidad del Salvador

  • Ricardo Macchi, Chair Prof · University of Buenos Aires

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04846114 on ClinicalTrials.gov